Your browser doesn't support javascript.
loading
Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact.
Macchi, Chiara; Ferri, Nicola; Sirtori, Cesare R; Corsini, Alberto; Banach, Maciej; Ruscica, Massimiliano.
Affiliation
  • Macchi C; Department of Pharmacological and Biomolecular Sciences, Universita' degli Studi di Milano, Italy. Electronic address: chiara.macchi@unimi.it.
  • Ferri N; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy.
  • Sirtori CR; Department of Pharmacological and Biomolecular Sciences, Universita' degli Studi di Milano, Italy.
  • Corsini A; Department of Pharmacological and Biomolecular Sciences, Universita' degli Studi di Milano, Italy; Istituti di Ricovero e Cura a Carattere Scientifico MultiMedica, Sesto San Giovanni/Milan, Italy.
  • Banach M; Department of Hypertension, Medical University of Lodz, Lodz, Poland; Polish Mother's Memorial Hospital Research Institute, Lodz, Poland; Cardiovascular Research Centre, University of Zielona Góra, Zielona Góra, Poland.
  • Ruscica M; Department of Pharmacological and Biomolecular Sciences, Universita' degli Studi di Milano, Italy. Electronic address: massimiliano.ruscica@unimi.it.
Am J Pathol ; 191(8): 1385-1397, 2021 08.
Article in En | MEDLINE | ID: mdl-34019847
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proprotein Convertase 9 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proprotein Convertase 9 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2021 Type: Article